Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain

Author

Fernández de Larrea Baz, Nerea

Michel, Angelika

Romero, Beatriz

Pérez Gómez, Beatriz

Moreno Aguado, Víctor

Martín Sánchez, Vicente

Dierssen Sotos, Trinidad

Jiménez Moleón, José Juan

Castilla, Jesús

Tardón, Adonina

Ruiz, Irune

Peiró Pérez, Rosana

Tejada, Antonio

Chirlaque, María Dolores

Butt, Julia A.

Olmedo Requena, Rocío

Gómez Acebo, Inés

Linares, Pedro

Boldo, Elena

Castells Garangou, Antoni

Pawlita, Michael

Castaño-Vinyals, Gemma

Kogevinas, Manolis

Sanjosé Llongueras, Silvia de

Pollán, Marina

Campo, Rosa del

Waterboer, Tim

Aragonès Sanz, Núria

Publication date

2019-09-12T10:05:00Z

2019-09-12T10:05:00Z

2017-05-29

2019-09-12T10:05:00Z

Abstract

Background: Several studies have suggested that Helicobacter pylori (H. pylori) infection is a risk factor for colorectal cancer (CRC), while others have not confirmed this hypothesis. This work aimed to assess the relation of CRC with H. pylori seropositivity and with seropositivity to 16 H. pylori proteins, in the MultiCase-Control study, MCC-Spain.Methods: MCC-Spain is a multicase-control study carried out in Spain from 2008 to 2013. In total, 2,140 histologically-confirmed incident CRC cases and 4,098 population-based controls were recruited. Controls were frequency-matched by sex, age, and province. Epidemiological data were collected through a questionnaire fulfilled by face-to-face interviews and a self-administered food-frequency questionnaire. Seroreactivities against 16 H. pylori proteins were determined in 1,488 cases and 2,495 controls using H. pylori multiplex serology. H. pylori seropositivity was defined as positivity to >= 4 proteins. Multivariable logistic regression mixed models were used to estimate odds ratios (OR) and 95% confidence intervals (CI).Results: H. pylori seropositivity was not associated with increased CRC risk (OR = 0.91; 95% CI: 0.71-1.16). Among H. pylori seropositive subjects, seropositivity to Cag delta showed a lower CRC risk, and risk decreased with increasing number of proteins seropositive. Seropositivity to the most recognized virulence factors, CagA and VacA, was not associated with a higher CRC risk. No statistically significant heterogeneity was identified among tumor sites, although inverse relations were stronger for left colon cancer. An interaction with age and sex was found: H. pylori seropositivity was associated with a lower CRC risk in men younger than 65 and with a higher risk in older women.Conclusions: Our results suggest that neither H. pylori seropositivity, nor seropositivity to the virulence factor CagA are associated with a higher CRC risk. A possible effect modification by age and sex was identified.

Document Type

Article
Published version

Language

English

Subjects and keywords

Helicobacteri pilòric; Càncer colorectal; Helicobacter pylori; Colorectal cancer

Publisher

Frontiers Media

Related items

Reproducció del document publicat a: https://doi.org/10.3389/fmicb.2017.00888

Frontiers in Microbiology, 2017, vol. 8

https://doi.org/10.3389/fmicb.2017.00888

Rights

cc-by (c) Fernández de Larrea Baz, Nerea et al., 2017

http://creativecommons.org/licenses/by/3.0/es